Benjamin Marhan Dropkin

Benjamin Dropkin practices at Prisma Health University Medical Group in Greenville, South Carolina.

Benjamin Dropkin's NPI, 1295122349, was assigned on April 15, 2015. Benjamin Dropkin holds Kentucky license 54815.

Benjamin Dropkin's primary practice is Prisma Health University Medical Group, at 48 Centennial Way, Greenville, SC 29605 in Greenville County. The practice phone is (864) 454-2000.

Benjamin Dropkin's primary practice is Prisma Health University Medical Group in Greenville, South Carolina. Benjamin Dropkin is also affiliated with Prisma Health Greenville Memorial Hospital. The medical group on file is Prisma Health Medical Group. Dmand AI also links Benjamin Dropkin to 3 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Benjamin Dropkin practices, 7 sites in all. Vendor and product names are available with a free account.

Urology is Benjamin Dropkin's primary specialty in the NPI Registry, under taxonomy code 208800000X. Benjamin Dropkin is licensed in Kentucky.

CMS data shows 248 Medicare services from Benjamin Dropkin across 11 procedure codes in 2024, for 159 Medicare patients. Medicare paid $18,289 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 159 Medicare patients who saw Benjamin Dropkin in 2024. The largest group is 65 to 74, with 65 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 26% are also on Medicaid. Their average risk score is 2.19, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Benjamin Dropkin's median patient age at 56, with 13% women.

In 2024, Benjamin Dropkin wrote 33 Medicare Part D claims for 24 patients. 82% of them were for generic drugs. They cover 4 drugs, with $496 in total drug cost. In 2020, CMS named 129 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Benjamin Dropkin for performance year 2024, reported as part of a group. Benjamin Dropkin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 7 papers to Benjamin Dropkin, published from 2022 to 2025. 2023 was the busiest year, with 2. The most frequent topics are Urology and Internship and Residency. Benjamin Dropkin has published most often in Urology. Benjamin Dropkin's most frequent co-authors are Allen Frank Morey, MD, Jason Robert Bylund, MD and Steven Jeffrey Hudak, MD.

CMS Open Payments shows 200 general payments to Benjamin Dropkin from 9 drug and device companies from 2017 to 2025. Grants make up the largest share, 77% of the total. Boston Scientific Corporation paid the most, $62,175.